vs
CENTERSPACE（CSR）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
CENTERSPACE的季度营收约是RHYTHM PHARMACEUTICALS, INC.的1.2倍（$66.6M vs $57.3M），CENTERSPACE净利率更高（-27.7% vs -83.0%，领先55.3%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（36.9% vs 0.3%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（48.5% vs 1.6%）
Centerspace是一家专注于多户住宅物业持有、运营与开发的房地产投资企业，核心业务覆盖美国中西部及落基山西部区域，面向不同租户群体提供经济型及高端住宅选择，重视租户体验与资产长期价值增长。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
CSR vs RYTM — 直观对比
营收规模更大
CSR
是对方的1.2倍
$57.3M
营收增速更快
RYTM
高出36.6%
0.3%
净利率更高
CSR
高出55.3%
-83.0%
两年增速更快
RYTM
近两年复合增速
1.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $66.6M | $57.3M |
| 净利润 | $-18.4M | $-47.5M |
| 毛利率 | 96.5% | 91.6% |
| 营业利润率 | -15.9% | -82.2% |
| 净利率 | -27.7% | -83.0% |
| 营收同比 | 0.3% | 36.9% |
| 净利润同比 | -262.9% | -9.6% |
| 每股收益（稀释后） | $-1.08 | $-0.73 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSRRYTM
| Q4 25 | $66.6M | $57.3M | ||
| Q3 25 | $71.4M | $51.3M | ||
| Q2 25 | $68.5M | $48.5M | ||
| Q1 25 | $67.1M | $32.7M | ||
| Q4 24 | $66.4M | $41.8M | ||
| Q3 24 | $65.0M | $33.3M | ||
| Q2 24 | $65.0M | $29.1M | ||
| Q1 24 | $64.5M | $26.0M |
净利润CSRRYTM
| Q4 25 | $-18.4M | $-47.5M | ||
| Q3 25 | $53.8M | $-52.9M | ||
| Q2 25 | $-14.5M | $-46.6M | ||
| Q1 25 | $-3.7M | $-49.5M | ||
| Q4 24 | $-5.1M | $-43.3M | ||
| Q3 24 | $-1.0M | $-43.6M | ||
| Q2 24 | $-1.3M | $-32.3M | ||
| Q1 24 | $-3.9M | $-141.4M |
毛利率CSRRYTM
| Q4 25 | 96.5% | 91.6% | ||
| Q3 25 | 96.5% | 89.3% | ||
| Q2 25 | 96.5% | 88.6% | ||
| Q1 25 | 96.4% | 88.8% | ||
| Q4 24 | 96.5% | 90.9% | ||
| Q3 24 | 96.6% | 88.5% | ||
| Q2 24 | 96.6% | 89.9% | ||
| Q1 24 | 96.4% | 89.2% |
营业利润率CSRRYTM
| Q4 25 | -15.9% | -82.2% | ||
| Q3 25 | — | -102.6% | ||
| Q2 25 | -9.9% | -93.4% | ||
| Q1 25 | 7.1% | -143.7% | ||
| Q4 24 | 4.3% | -98.6% | ||
| Q3 24 | 9.8% | -132.0% | ||
| Q2 24 | 11.1% | -139.2% | ||
| Q1 24 | 6.3% | -538.7% |
净利率CSRRYTM
| Q4 25 | -27.7% | -83.0% | ||
| Q3 25 | 75.3% | -103.1% | ||
| Q2 25 | -21.2% | -96.1% | ||
| Q1 25 | -5.6% | -151.4% | ||
| Q4 24 | -7.6% | -103.6% | ||
| Q3 24 | -1.6% | -131.2% | ||
| Q2 24 | -2.0% | -110.9% | ||
| Q1 24 | -6.1% | -544.4% |
每股收益（稀释后）CSRRYTM
| Q4 25 | $-1.08 | $-0.73 | ||
| Q3 25 | $3.19 | $-0.82 | ||
| Q2 25 | $-0.87 | $-0.75 | ||
| Q1 25 | $-0.22 | $-0.81 | ||
| Q4 24 | $-0.31 | $-0.71 | ||
| Q3 24 | $-0.40 | $-0.73 | ||
| Q2 24 | $-0.19 | $-0.55 | ||
| Q1 24 | $-0.37 | $-2.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.8M | $388.9M |
| 总债务越低越好 | $1.0B | — |
| 股东权益账面价值 | $719.2M | $139.1M |
| 总资产 | $1.9B | $480.2M |
| 负债/权益比越低杠杆越低 | 1.42× | — |
8季度趋势，按日历期对齐
现金及短期投资CSRRYTM
| Q4 25 | $12.8M | $388.9M | ||
| Q3 25 | $12.9M | $416.1M | ||
| Q2 25 | $12.4M | $291.0M | ||
| Q1 25 | $11.9M | $314.5M | ||
| Q4 24 | $12.0M | $320.6M | ||
| Q3 24 | $14.5M | $298.4M | ||
| Q2 24 | $14.3M | $319.1M | ||
| Q1 24 | $12.7M | $201.2M |
总债务CSRRYTM
| Q4 25 | $1.0B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $955.5M | — | ||
| Q4 24 | $955.4M | — | ||
| Q3 24 | $921.3M | — | ||
| Q2 24 | $931.7M | — | ||
| Q1 24 | $929.1M | — |
股东权益CSRRYTM
| Q4 25 | $719.2M | $139.1M | ||
| Q3 25 | $748.6M | $148.8M | ||
| Q2 25 | $710.1M | $-11.9M | ||
| Q1 25 | $636.8M | $18.9M | ||
| Q4 24 | $752.0M | $21.7M | ||
| Q3 24 | $672.5M | $11.2M | ||
| Q2 24 | $680.7M | $39.3M | ||
| Q1 24 | $688.1M | $61.6M |
总资产CSRRYTM
| Q4 25 | $1.9B | $480.2M | ||
| Q3 25 | $2.1B | $506.9M | ||
| Q2 25 | $2.0B | $372.7M | ||
| Q1 25 | $1.9B | $386.7M | ||
| Q4 24 | $1.9B | $392.3M | ||
| Q3 24 | $1.9B | $363.6M | ||
| Q2 24 | $1.9B | $381.8M | ||
| Q1 24 | $1.9B | $258.7M |
负债/权益比CSRRYTM
| Q4 25 | 1.42× | — | ||
| Q3 25 | 1.53× | — | ||
| Q2 25 | 1.57× | — | ||
| Q1 25 | 1.50× | — | ||
| Q4 24 | 1.27× | — | ||
| Q3 24 | 1.37× | — | ||
| Q2 24 | 1.37× | — | ||
| Q1 24 | 1.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $98.5M | $-25.4M |
| 自由现金流经营现金流 - 资本支出 | $64.3M | — |
| 自由现金流率自由现金流/营收 | 96.5% | — |
| 资本支出强度资本支出/营收 | 51.3% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $125.9M | — |
8季度趋势，按日历期对齐
经营现金流CSRRYTM
| Q4 25 | $98.5M | $-25.4M | ||
| Q3 25 | $35.1M | $-26.6M | ||
| Q2 25 | $25.3M | $-23.3M | ||
| Q1 25 | $25.4M | $-40.4M | ||
| Q4 24 | $98.2M | $-18.8M | ||
| Q3 24 | $32.3M | $-25.2M | ||
| Q2 24 | $22.9M | $-29.1M | ||
| Q1 24 | $24.4M | $-40.7M |
自由现金流CSRRYTM
| Q4 25 | $64.3M | — | ||
| Q3 25 | $25.7M | — | ||
| Q2 25 | $15.5M | — | ||
| Q1 25 | $20.4M | — | ||
| Q4 24 | $41.6M | — | ||
| Q3 24 | $20.5M | — | ||
| Q2 24 | $9.1M | — | ||
| Q1 24 | $2.6M | — |
自由现金流率CSRRYTM
| Q4 25 | 96.5% | — | ||
| Q3 25 | 36.0% | — | ||
| Q2 25 | 22.7% | — | ||
| Q1 25 | 30.4% | — | ||
| Q4 24 | 62.6% | — | ||
| Q3 24 | 31.5% | — | ||
| Q2 24 | 14.0% | — | ||
| Q1 24 | 4.0% | — |
资本支出强度CSRRYTM
| Q4 25 | 51.3% | — | ||
| Q3 25 | 13.1% | — | ||
| Q2 25 | 14.2% | — | ||
| Q1 25 | 7.5% | — | ||
| Q4 24 | 85.3% | — | ||
| Q3 24 | 18.2% | — | ||
| Q2 24 | 21.2% | — | ||
| Q1 24 | 33.8% | — |
现金转化率CSRRYTM
| Q4 25 | — | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSR
| Multi Family Residential | $57.3M | 86% |
| Other | $8.1M | 12% |
| Other Property Revenue | $1.2M | 2% |
RYTM
暂无分部数据
